David Tüller

3.2k total citations
57 papers, 2.0k citations indexed

About

David Tüller is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and General Health Professions. According to data from OpenAlex, David Tüller has authored 57 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Cardiology and Cardiovascular Medicine, 27 papers in Surgery and 11 papers in General Health Professions. Recurrent topics in David Tüller's work include Coronary Interventions and Diagnostics (26 papers), Cardiac Valve Diseases and Treatments (18 papers) and Acute Myocardial Infarction Research (14 papers). David Tüller is often cited by papers focused on Coronary Interventions and Diagnostics (26 papers), Cardiac Valve Diseases and Treatments (18 papers) and Acute Myocardial Infarction Research (14 papers). David Tüller collaborates with scholars based in Switzerland, United States and United Kingdom. David Tüller's co-authors include Stephan Windecker, Peter Wenaweser, Franz R. Eberli, Marco Roffi, Bernhard Meier, Peter Jüni, Otto M. Hess, Christian Seiler, Dik Heg and Mario Togni and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Circulation.

In The Last Decade

David Tüller

56 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Tüller Switzerland 22 1.4k 1.3k 477 412 177 57 2.0k
Miltos K. Lazarides Greece 32 618 0.5× 1.7k 1.3× 2.2k 4.6× 47 0.1× 186 1.1× 164 3.1k
Christopher Rao United Kingdom 26 975 0.7× 1.2k 1.0× 456 1.0× 136 0.3× 258 1.5× 85 2.1k
Liesbeth Lewi Belgium 44 237 0.2× 1.3k 1.0× 464 1.0× 99 0.2× 509 2.9× 211 6.9k
Sigrid Boczor Germany 19 1.2k 0.9× 244 0.2× 85 0.2× 193 0.5× 67 0.4× 57 1.6k
Gerard Devlin New Zealand 20 1.1k 0.8× 493 0.4× 138 0.3× 342 0.8× 133 0.8× 75 1.7k
Loree K. Kalliainen United States 22 206 0.2× 1.1k 0.9× 123 0.3× 268 0.7× 80 0.5× 61 2.0k
Ronen Jaffe Israel 19 933 0.7× 704 0.6× 235 0.5× 741 1.8× 115 0.6× 91 1.8k
I‐Seok Kang South Korea 20 486 0.4× 448 0.4× 548 1.1× 84 0.2× 600 3.4× 129 1.2k
Lem Moyé United States 11 712 0.5× 339 0.3× 101 0.2× 146 0.4× 72 0.4× 18 1.3k
John T. Wald United States 27 92 0.1× 1.2k 0.9× 309 0.6× 220 0.5× 139 0.8× 78 2.3k

Countries citing papers authored by David Tüller

Since Specialization
Citations

This map shows the geographic impact of David Tüller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Tüller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Tüller more than expected).

Fields of papers citing papers by David Tüller

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Tüller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Tüller. The network helps show where David Tüller may publish in the future.

Co-authorship network of co-authors of David Tüller

This figure shows the co-authorship network connecting the top 25 collaborators of David Tüller. A scholar is included among the top collaborators of David Tüller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Tüller. David Tüller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tüller, David & Mark Vink. (2023). Graded exercise therapy and cognitive behavior therapy do not improve employment outcomes in ME/CFS. Work. 74(4). 1235–1239. 2 indexed citations
2.
Wagener, Max, Oliver Reuthebuch, Dik Heg, et al.. (2023). Clinical Outcomes in High‐Gradient, Classical Low‐Flow, Low‐Gradient, and Paradoxical Low‐Flow, Low‐Gradient Aortic Stenosis After Transcatheter Aortic Valve Implantation: A Report From the SwissTAVI Registry. Journal of the American Heart Association. 12(12). e029489–e029489. 21 indexed citations
3.
4.
Geraghty, Keith, et al.. (2019). The ‘cognitive behavioural model’ of chronic fatigue syndrome: Critique of a flawed model. Health Psychology Open. 6(1). 4018375867–4018375867. 27 indexed citations
5.
O’Sullivan, Cróchán J., Rainer Zbinden, David J. Kurz, et al.. (2018). Screening For Pulmonary Hypertension With Multidetector Computed Tomography Among Patients With Severe Aortic Stenosis Undergoing Transcatheter Aortic Valve Implantation. Frontiers in Cardiovascular Medicine. 5. 63–63. 10 indexed citations
6.
O’Sullivan, Cróchán J., David Tüller, Rainer Zbinden, & Franz R. Eberli. (2016). Impact of Mitral Regurgitation on Clinical Outcomes After Transcatheter Aortic Valve Implantation. Interventional Cardiology Reviews Research Resources. 11(1). 54–54. 2 indexed citations
7.
8.
Pilgrim, Thomas, Raffaele Piccolo, Dik Heg, et al.. (2016). Biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents for primary percutaneous coronary revascularisation of acute myocardial infarction. EuroIntervention. 12(11). e1343–e1354. 22 indexed citations
9.
Koskinas, Konstantinos C., Masanori Taniwaki, Fabio Rigamonti, et al.. (2016). Impact of Patient and Lesion Complexity on Long-Term Outcomes Following Coronary Revascularization With New-Generation Drug-Eluting Stents. The American Journal of Cardiology. 119(4). 501–507. 9 indexed citations
10.
Díaz, Víctor Alfonso Jiménez, Andrés Íñiguez, José Antonio Baz, et al.. (2016). A randomized comparison of novel bioresorbable polymer sirolimus-eluting stent and durable polymer everolimus-eluting stent in patients with acute coronary syndromes: The CENTURY II high risk ACS substudy. Cardiovascular revascularization medicine. 17(6). 355–361. 17 indexed citations
11.
O’Sullivan, Cróchán J., David Tüller, Rainer Zbinden, & Franz R. Eberli. (2016). Impact of Mitral Regurgitation on Clinical Outcomes After Transcatheter Aortic Valve Implantation. Interventional Cardiology Reviews Research Resources. 11(1). 54–54. 8 indexed citations
12.
O’Sullivan, Cróchán J., Lars Englberger, Dik Heg, et al.. (2015). Clinical Outcomes and Revascularization Strategies in Patients With Low-Flow, Low-Gradient Severe Aortic Valve Stenosis According to the Assigned Treatment Modality. JACC: Cardiovascular Interventions. 8(5). 704–717. 36 indexed citations
13.
14.
15.
Sabaté, Manel, Lorenz Räber, Dik Heg, et al.. (2013). Comparison of Newer-Generation Drug-Eluting With Bare-Metal Stents in Patients With Acute ST-Segment Elevation Myocardial Infarction. JACC: Cardiovascular Interventions. 7(1). 55–63. 67 indexed citations
16.
Sabaté, Manel, Lorenz Räber, Dik Heg, et al.. (2012). TCT-481 Comparison of newer generation drug-eluting stents with bare metal stents in patients with acute ST-segment elevation myocardial infarction: A pooled analysis of EXAMINATION and COMFORTABLE AMI trials. Journal of the American College of Cardiology. 60(17). B139–B139. 1 indexed citations
17.
Räber, Lorenz, Henning Kelbæk, Andreas Baumbach, et al.. (2012). Comparison of biolimus eluted from an erodible stent coating with bare metal stents in acute ST-elevation myocardial infarction (COMFORTABLE AMI trial): rationale and design. EuroIntervention. 7(12). 1435–1443. 23 indexed citations
18.
19.
Windecker, Stephan, Andréa Remondino, Franz R. Eberli, et al.. (2005). Sirolimus-Eluting and Paclitaxel-Eluting Stents for Coronary Revascularization. New England Journal of Medicine. 353(7). 653–662. 431 indexed citations
20.
Wenaweser, Peter, Franz R. Eberli, Mario Togni, et al.. (2005). Stent thrombosis following bare-metal stent implantation: success of emergency percutaneous coronary intervention and predictors of adverse outcome. European Heart Journal. 26(12). 1180–1187. 138 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Miltos K. Lazarides Breakdown of academic impact, for papers by Christopher Rao Breakdown of academic impact, for papers by Liesbeth Lewi Breakdown of academic impact, for papers by Sigrid Boczor Breakdown of academic impact, for papers by Gerard Devlin Breakdown of academic impact, for papers by Loree K. Kalliainen Breakdown of academic impact, for papers by Ronen Jaffe Breakdown of academic impact, for papers by I‐Seok Kang Breakdown of academic impact, for papers by Lem Moyé Breakdown of academic impact, for papers by John T. Wald
Rankless by CCL
2026